This is a review about progesterone receptor, based on 36 published articles (read how Labome selects the articles), using progesterone receptor antibody in all methods. It is aimed to help Labome visitors find the most suited progesterone receptor antibody.
progesterone receptor synonym: NR3C3; nuclear receptor subfamily 3 group C member 3

EMD MilliporeEMD Millipore progesterone receptor product
  • immunohistochemistryHiroki Utsunomiya et al. utilized EMD Millipore progesterone receptor antibody to study the steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma [ncbi , more ] in 2004 and Takashi Suzuki et al. used EMD Millipore progesterone receptor antibody to study the biological significance of estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor (catalog: MAB429) [ncbi , more ].
  • western blotIn 2005, Diane Palmieri et al. used EMD Millipore progesterone receptor antibody to study Nm23-H1 expression in hormone receptor negative breast cancer [ncbi , more ].
Santa Cruz BiotechnologySanta Cruz Biotechnology progesterone receptor product
  • ChIP assayIn 2008, Emily J Faivre et al. applied Santa Cruz Biotechnology progesterone receptor antibody to study the role of progestin-stimulated rapid PR signaling in the transcriptional regulation of target genes involved in breast cancer cell proliferation [ncbi , more ].
  • immunohistochemistryIn 2009, Sandra Dupouy et al. used Santa Cruz Biotechnology progesterone receptor antibody to investigate the role of neurotensin receptor-1 pathway in the regulation of human ductal breast cancer progression [ncbi , more ]. In 2003, Vernon Pais et al. used Santa Cruz Biotechnology progesterone receptor antibody to detect PR in the human specimens of a section of a seminiferous tubule adjacent to a seminoma or a section of a seminoma [ncbi , more ].
  • immunoprecipitationIn 2008, Sanhita Ray et al. used Santa Cruz Biotechnology progesterone receptor antibody to demonstrate that integration beta-catenin/Lef-1/Tcf-3 signaling with ERalpha is necessary for estrogen-dependent endogenous gene regulation in uterine biology (catalog: sc-539) [ncbi , more ].
  • western blotIn 2009, Haggar Harduf et al. utilized Santa Cruz Biotechnology progesterone receptor antibody to do western blot in order to investigate the role of the progesterone receptor A and c-Met in spheroids-endometrium [ncbi , more ]. In 2008, Sanhita Ray et al. used Santa Cruz Biotechnology progesterone receptor antibody to demonstrate that integration beta-catenin/Lef-1/Tcf-3 signaling with ERalpha is necessary for estrogen-dependent endogenous gene regulation in uterine biology (catalog: sc-539) [ncbi , more ].
Life Technologies CorporationLife Technologies Corporation progesterone receptor product
  • immunohistochemistryIn 2009, Wei Zhou et al. employed Life Technologies Corporation progesterone receptor antibody to demonstrate whether overexpression of EMP3 in primary breast carcinoma is not associated with DNA methylation [ncbi , more ].
  • immunoprecipitationIn 2008, Emily J Faivre et al. applied Life Technologies Corporation progesterone receptor antibody to study the role of progestin-stimulated rapid PR signaling in the transcriptional regulation of target genes involved in breast cancer cell proliferation [ncbi , more ].
  • western blotIn 2008, Emily J Faivre et al. applied Life Technologies Corporation progesterone receptor antibody to study the role of progestin-stimulated rapid PR signaling in the transcriptional regulation of target genes involved in breast cancer cell proliferation [ncbi , more ].
Thermo Scientific Pierce ProductsThermo Scientific Pierce Products progesterone receptor product
  • immunohistochemistryIn 2003, Weiguo Wu et al. applied Thermo Scientific Pierce Products progesterone receptor antibody to study the coordinate expression of Cdc25B and the role of ER-alpha in high-grade endometrioid and nonendometrioid carcinomas [ncbi , more ].
  • western blotIn 2009, Cecilia J Proietti et al. used Thermo Scientific Pierce Products progesterone receptor antibody to carry out western blot analysis in order to investigate the cross talk between ErbB2 and PR receptor signaling and the effect on stat3 activation and breast cancer growth [ncbi , more ]. In 2008, Emily J Faivre et al. applied Thermo Scientific Pierce Products progesterone receptor antibody to study the role of progestin-stimulated rapid PR signaling in the transcriptional regulation of target genes involved in breast cancer cell proliferation [ncbi , more ].
DakoDako progesterone receptor product
  • immunocytochemistryIn 2002, P S Quadros et al. employed Dako progesterone receptor antibody to show that that differences in steroid secretion by the neonatal male and female gonads are responsible for producing sex differences in the level of PR expression in the postnatal MPN [ncbi , more ].
  • immunohistochemistryIn 2010, Aylin Ege Gul et al. used Dako progesterone receptor antibody to perform immunohistochemistry in order to [ncbi , more ]. Dako progesterone receptor antibody was employed in 2008 to perform immunohistochemistry in order to study the ureteral endometriosis [ncbi , more ], to perform immunohistochemistry in order to study the correlation between the pathologic type of breast cancer and the overexpressed and altered localized atypical protein kinase C lambda/iota [ncbi , more ], to investigate the expressions of EGFR and pEGFR and their correlation with overall and disease-free survival, clinicopathological parameters and biological markers of invasion and angiogenesis [ncbi , more ], to study the expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer [ncbi , more ], to investigate the predictive value of clinical and biological markers for a pathological complete remission after a preoperative dose-dense regimen of doxorubicin and docetaxel, with or without tamoxifen, in primary operable breast cancer [ncbi , more ], to perform immunohistochemistry in order to study the relationship between lymph nodes(LN) metastases and CD1a+ mononuclear cells, and the role of CD1a in breast cancer [ncbi , more ]and to identify biomarkers in ductal carcinoma in situ of the breast with microinvasion in paraffin sections from human tumor [ncbi , more ]. In 2005, Agnieszka K Witkiewicz et al. utilized Dako progesterone receptor antibody to study the association of alpha-Methylacyl-CoA racemase protein expression with the degree of differentiation in breast cancer [ncbi , more ]. Dako progesterone receptor antibody was applied in 2004 to detect progesterone receptor in invasive lobular carcinoma breast tumor sections [ncbi , more ], to detect progesterone receptor in adjacent serial sections of two breast invasive ductal carcinomas from patients [ncbi , more ]and to study the function of HMGA1 protein expression for the diagnosis and prognosis of human breast cancer [ncbi , more ]. In 2003, Andrea Decensi et al. utilized Dako progesterone receptor antibody to study the effect of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers [ncbi , more ].
  • western blotIn 2004, Torsten A Hopp et al. utilized Dako progesterone receptor antibody to detect PgR in protein extract of a cohort of frozen primary breast tumor specimens from 305 axillary lymph node-positive patients [ncbi , more ].
Biogenex
  • immunohistochemistryIn 2007, Marjan Berishaj et al. applied Biogenex progesterone receptor antibody to study the role for IL-6 in driving Stat3 activation in breast cancer [ncbi , more ]. Ashka Y Pandya et al. used Biogenex progesterone receptor antibody to study nuclear localization of KLF4 in early-stage breast cancer [ncbi , more ] in 2004 and Anna Maria Granato et al. used Biogenex progesterone receptor antibody to detect progesterone receptor in tumor tissue from patients with breast cancer [ncbi , more ].
Leica Microsystems
  • immunocytochemistryIn 2006, Marius C Jones et al. applied Leica Microsystems progesterone receptor antibody to perform western blot, immunoprecipitation, and immunofluorescence in order to study the process of cAMP signaling induced dynamic changes in the SUMO pathway determine the endometrial response to progesterone [ncbi , more ].
  • immunohistochemistryIn 2009, Donghui Zou et al. employed Leica Microsystems progesterone receptor antibody to carry out immunofluorescence assays in order to study whether c-Src kinase contributes the progression from atypical lobular hyperplasia, and lobular carcinoma in situ to invasive lobular carcinoma [ncbi , more ]. In 2008, Nuran Bektas et al. applied Leica Microsystems progesterone receptor antibody to perform immunohistochemistry at 1:20 dilution in order to show that the ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) was identified as a a novel human breast tumour marker [ncbi , more ]. In 2004, Meera Srivastava et al. employed Leica Microsystems progesterone receptor antibody to study whether levels of ANX7 correlate with breast cancer progression and survival in paraffin sections from human tumor [ncbi , more ].
  • immunoprecipitationIn 2006, Marius C Jones et al. applied Leica Microsystems progesterone receptor antibody to perform western blot, immunoprecipitation, and immunofluorescence in order to study the process of cAMP signaling induced dynamic changes in the SUMO pathway determine the endometrial response to progesterone [ncbi , more ].
  • western blotMarius C Jones et al. applied Leica Microsystems progesterone receptor antibody to perform western blot, immunoprecipitation, and immunofluorescence in order to study the process of cAMP signaling induced dynamic changes in the SUMO pathway determine the endometrial response to progesterone [ncbi , more ] in 2006 and Maribeth A Lazzaro et al. used Leica Microsystems progesterone receptor antibody to study the regulation of steroidogenic acute regulatory protein expression by imitation switch protein SNF2L during terminal differentiation of ovarian granulosa cells [ncbi , more ].
Roche Applied Science
  • immunohistochemistryIn 2008, Masaki Hasegawa et al. utilized Roche Applied Science progesterone receptor antibody to perform immunohistochemistry in order to study the signification of the expression of CD109 in basal-like breast carcinoma [ncbi , more ]. In 2006, Abbas Fotovati et al. applied Roche Applied Science progesterone receptor antibody to study the role of 17 estradiol for down-regulation of Cap43/NDRG1/Drg-1 in human breast cancer cells [ncbi , more ].
Articles Reviewed
  1. Aylin Ege Gul et al. (2010). "The relationship of cerb B 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas".PMID 20167054
  2. Donghui Zou et al. (2009). "Increased levels of active c-Src distinguish invasive from in situ lobular lesions".PMID 19583841
  3. Wei Zhou et al. (2009). "EMP3 overexpression in primary breast carcinomas is not associated with epigenetic aberrations".PMID 19270820
  4. Haggar Harduf et al. (2009). "Progesterone receptor A and c-Met mediates spheroids-endometrium attachment".PMID 19220894
  5. Sandra Dupouy et al. (2009). "The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression".PMID 19156213
  6. Cecilia J Proietti et al. (2009). "Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth".PMID 19103753
  7. Yasuhiro Okumura et al. (2008). "Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion".PMID 18837981
  8. Nuran Bektas et al. (2008). "The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer".PMID 18627608
  9. Maha Al-Khawaja et al. (2008). "Ureteral endometriosis: clinicopathological and immunohistochemical study of 7 cases".PMID 18538172
  10. Yasuyuki Kojima et al. (2008). "The overexpression and altered localization of the atypical protein kinase C lambda/iota in breast cancer correlates with the pathologic type of these tumors".PMID 18538170
  11. Christina Magkou et al. (2008). "Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas".PMID 18522728
  12. Yasmine Nadler et al. (2008). "Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer".PMID 18430249
  13. Masaki Hasegawa et al. (2008). "CD109 expression in basal-like breast carcinoma".PMID 18429827
  14. Gunter von Minckwitz et al. (2008). "Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast".PMID 18380893
  15. Emily J Faivre et al. (2008). "Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors".PMID 18202149
  16. Sanhita Ray et al. (2008). "Cooperative control via lymphoid enhancer factor 1/T cell factor 3 and estrogen receptor-alpha for uterine gene regulation by estrogen".PMID 18202148
  17. G La Rocca et al. (2008). "CD1a down-regulation in primary invasive ductal breast carcinoma may predict regional lymph node invasion and patient outcome".PMID 18184269
  18. Marjan Berishaj et al. (2007). "Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer".PMID 17531096
  19. Marius C Jones et al. (2006). "Regulation of the SUMO pathway sensitizes differentiating human endometrial stromal cells to progesterone".PMID 17053081
  20. Maribeth A Lazzaro et al. (2006). "The imitation switch protein SNF2L regulates steroidogenic acute regulatory protein expression during terminal differentiation of ovarian granulosa cells".PMID 16740656
  21. Abbas Fotovati et al. (2006). "17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells".PMID 16707596
  22. Agnieszka K Witkiewicz et al. (2005). "Alpha-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis".PMID 15941950
  23. Diane Palmieri et al. (2005). "Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer".PMID 15870434
  24. Gennaro Chiappetta et al. (2004). "HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expression".PMID 15569996
  25. Torsten A Hopp et al. (2004). "Low levels of estrogen receptor beta protein predict resistance to tamoxifen therapy in breast cancer".PMID 15569979
  26. Daniel G Hayward et al. (2004). "The centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancer".PMID 15492258
  27. Hiroki Utsunomiya et al. (2004). "Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma".PMID 15355916
  28. Majida Esslimani-Sahla et al. (2004). "Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer".PMID 15355905
  29. Takashi Suzuki et al. (2004). "Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor".PMID 15231680
  30. Ashka Y Pandya et al. (2004). "Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer".PMID 15102675
  31. Meera Srivastava et al. (2004). "Prognostic impact of ANX7-GTPase in metastatic and HER2-negative breast cancer patients".PMID 15073110
  32. Anna Maria Granato et al. (2004). "Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools?".PMID 14680499
  33. Weiguo Wu et al. (2003). "Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas".PMID 14559803
  34. Vernon Pais et al. (2003). "Estrogen receptor-beta expression in human testicular germ cell tumors".PMID 14555521
  35. Andrea Decensi et al. (2003). "A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers".PMID 12783932
  36. P S Quadros et al. (2002). "Regulation of sex differences in progesterone receptor expression in the medial preoptic nucleus of postnatal rats".PMID 12372000